GSK Net Worth 2010-2023 | GSK

Interactive chart of historical net worth (market cap) for GSK (GSK) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. GSK net worth as of June 02, 2023 is $69.2B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $69.205B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.883B 8.30
Bio-Rad Laboratories (BIO.B) United States $11.071B 29.60
QIAGEN (QGEN) Netherlands $10.425B 22.01
Ginkgo Bioworks Holdings (DNA) United States $3.504B 0.00
Arcus Biosciences (RCUS) United States $1.484B 0.00
Biohaven (BHVN) United States $1.414B 0.00
Emergent Biosolutions (EBS) United States $0.414B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.183B 0.00
Enzo Biochem (ENZ) United States $0.109B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00